|
|
Article: Helicos BioSciences Q3 2009 Operating Highlights and Strategic Update.
- Article from:
- Cancer Weekly
- Article date:
- November 10, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Helicos BioSciences Corporation (NASDAQ: HLCS) announced its operational, technical and scientific highlights for the quarter ended September 30, 2009 (see also Helicos BioSciences Corporation).
"In the third quarter of 2009, we continued to accelerate the deployment of our Helicos[R] Genetic Analysis System and to advance our technology. System orders more than doubled during the third quarter of 2009 compared to the first half of 2009 which resulted in an increase in the number of System installations from six to eleven during the quarter. We continue our drive to install our Systems in some of the world's most distinguished research sites. I am pleased to see ...